CC
CME icon

ClearArc Capital’s CME Group CME Stock Holding History

ClearArc Capital’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$768K Sell
3,824
-1,586
-29% -$325K 0.3% 80
2019
Q3 		$1.14M Buy
5,410
+69
+1% +$14.4K 0.33% 71
2019
Q2 		$1.04M Sell
5,341
-663
-11% -$122K 0.31% 76
2019
Q1 		$988K Sell
6,004
-135
-2% -$23.9K 0.27% 92
2018
Q4 		$1.16M Sell
6,139
-21,484
-78% -$3.97M 0.35% 73
2018
Q3 		$4.7M Sell
27,623
-407
-1% -$68.5K 0.62% 37
2018
Q2 		$4.59M Buy
28,030
+658
+2% +$107K 0.65% 34
2018
Q1 		$4.43M Buy
27,372
+18,118
+196% +$2.88M 0.67% 37
2017
Q4 		$1.35M Sell
9,254
-86
-0.9% -$12.2K 0.18% 123
2017
Q3 		$1.27M Buy
9,340
+404
+5% +$51K 0.19% 122
2017
Q2 		$1.12M Sell
8,936
-13,095
-59% -$1.57M 0.18% 137
2017
Q1 		$2.62M Buy
22,031
+13,191
+149% +$1.59M 0.44% 61
2016
Q4 		$1.02M Buy
8,840
+3
+0% +$334 0.18% 134
2016
Q3 		$924K Buy
8,837
+613
+7% +$64K 0.17% 138
2016
Q2 		$801K Sell
8,224
-15
-0.2% -$1.42K 0.16% 151
2016
Q1 		$791K Sell
8,239
-32
-0.4% -$2.91K 0.17% 150
2015
Q4 		$749K Buy
8,271
+56
+0.7% +$5.27K 0.16% 159
2015
Q3 		$762K Buy
8,215
+359
+5% +$34.1K 0.16% 170
2015
Q2 		$731K Buy
7,856
+997
+15% +$93K 0.13% 194
2015
Q1 		$650K Buy
6,859
+121
+2% +$11.2K 0.13% 193
2014
Q4 		$597K Buy
6,738
+207
+3% +$17.5K 0.12% 201
2014
Q3 		$522K Buy
6,531
+196
+3% +$14.8K 0.12% 209
2014
Q2 		$449K Buy
6,335
+85
+1% +$5.98K 0.1% 227
2014
Q1 		$463K Buy
6,250
+385
+7% +$29K 0.11% 217
2013
Q4 		$460K Sell
5,865
-82
-1% -$6.42K 0.12% 201
2013
Q3 		$439K Buy
5,947
+59
+1% +$4.35K 0.12% 198
2013
Q2 		$447K Buy
+5,888
New +$386K 0.12% 191

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearArc Capital's CME Position: Q4 2019 in Review

ClearArc Capital reduced its CME Group (CME) stake by 29% in Q4 2019, selling an estimated $325K and leaving 3,824 shares worth $768K. The position accounts for 0.3% of the portfolio, ranked #80.

ClearArc Capital first reported a position in CME in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.7M in Q3 2018. 1,061 funds tracked by Wall St. Rank hold CME as of Q4 2019.

  • ClearArc Capital held 3,824 shares of CME Group worth $768K as of Q4 2019.
  • ClearArc Capital sold 1,586 CME Group shares in Q4 2019, an estimated $325K.
  • CME Group made up 0.3% of ClearArc Capital's portfolio in Q4 2019, its #80 holding.
  • ClearArc Capital first reported a position in CME Group in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's CME Group position peaked at $4.7M in Q3 2018.
  • 1,061 funds tracked by Wall St. Rank held CME Group as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.